Security
Immunoprecise Antibodies Ltd. Ordinary Shares · IPATF
IPATFOTCCommon stockHistorical · closed Dec 30, 2020CIK 1715925Updated Nov 1, 2026
Name history
ImmunoPrecise Antibodies Ltd. · through Sep 3, 2025
Current securities for this SEC filerHYFT · NASDAQIPA · NEO
IPATF price & chart
About the company
MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio-Native AI company building the BioIntelligence infrastructure that life sciences AI and agentic AI require, integrating AI, data, and advanced wet lab capabilities into one connected discovery ecosystem. At its core is HYFT® Technology, a proprietary, function-aware representation of biology. Its HYFT fingerprints span sequence and structural biology and, refined over 20 years of curation, form a continuously evolving biological representation of 660 million patterns and 25 billion relationships. This enriched biological representation is the architecture behind ReefIQ™, the biological data substrate that provides context for life sciences, enriching data at ingestion and growing more valuable with each program run on it, and LensAI™, the reasoning and application layer for target discovery, candidate diligence, portfolio decision support, and the agentic AI workflows pharma is racing to deploy. By design, value compounds in this HYFT representation layer, not in any individual AI model that runs on top of it.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · CADSource
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Profit or LossCAD | — | — | -3,930,000Source | -21,521,000Source | -2,679,000Source | -2,553,000Source | -2,409,000Source | -3,999,000Source | -30,234,000Source | -27,177,000Source | -26,560,000Source | -16,709,000Source |
| Additional Financial Items | ||||||||||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableCAD | — | — | — | — | — | — | — | 1,274,000Source | -298,000Source | -601,000Source | -561,000Source | 163,000Source |
| AdjustmentsForSharebasedPaymentsCAD | — | — | — | — | — | — | — | 165,000Source | 445,000Source | 1,535,000Source | 1,943,000Source | 3,083,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsCAD | — | — | — | — | — | — | — | 155,000Source | 622,000Source | 15,000Source | -146,000Source | -519,000Source |
| General and Administrative ExpenseCAD | — | — | 3,124,000Source | 2,864,000Source | 4,178,000Source | 2,854,000Source | 3,308,000Source | 3,354,000Source | 14,735,000Source | 15,592,000Source | 19,812,000Source | 1,165,000Source |
| GoodwillCAD | — | — | 0Source | 7,871,000Source | 18,664,000Source | — | — | — | 8,230,000Source | 7,687,000Source | 19,171,000Source | 19,703,000Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesCAD | — | — | — | — | — | — | — | 394,000Source | 1,577,000Source | 1,339,000Source | 1,337,000Source | 962,000Source |
| ProceedsFromIssuingSharesCAD | — | — | — | — | — | — | — | — | 12,228,000Source | 2,360,000Source | 716,000Source | 3,850,000Source |
| AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Total RevenueCAD | — | — | 4,158,000Source | 2,728,000Source | 6,221,000Source | 2,679,000Source | 6,150,000Source | 2,473,000Source | 24,520,000Source | 24,518,000Source | 20,665,000Source | 19,364,000Source |
| Additional Financial Items | ||||||||||||
| ApplicableTaxRatenumber | — | — | — | — | — | — | — | — | 0.27Source | 0.27Source | 0.27Source | 0.27Source |
| BasicEarningsLossPerShareCAD/shares | — | — | — | -0.66Source | -0.1Source | — | -0.1Source | — | -0.91Source | -1.06Source | — | — |
| CurrentTaxExpenseIncomeCAD | — | — | — | — | — | — | — | — | 185,000Source | 177,000Source | -242,000Source | 1,390,000Source |
| DeferredTaxExpenseIncomeCAD | — | — | — | — | — | — | — | — | -4,218,000Source | -1,703,000Source | -950,000Source | -529,000Source |
| DepreciationAndAmortisationExpenseCAD | — | — | — | — | — | — | — | — | — | — | — | 2,567,000Source |
| DilutedEarningsLossPerShareCAD/shares | — | — | — | -0.66Source | -0.1Source | — | -0.1Source | — | -0.91Source | -1.06Source | — | — |
| EmployeeBenefitsExpenseCAD | — | — | 3,170,000Source | 2,053,000Source | 3,077,000Source | 2,349,000Source | 3,491,000Source | 2,362,000Source | 12,233,000Source | 14,040,000Source | 14,435,000Source | — |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesCAD | — | — | 257,000Source | 70,000Source | 178,000Source | 176,000Source | 297,000Source | 146,000Source | 445,000Source | 1,535,000Source | 1,943,000Source | 3,083,000Source |
| ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsedCAD | — | — | — | — | — | — | — | 3,000Source | — | 7,000Source | 40,000Source | 32,000Source |
| ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilitiesCAD | — | — | — | — | — | — | — | 125,000Source | 567,000Source | 467,000Source | 215,000Source | 136,000Source |
| FinanceCostsCAD | — | — | — | — | — | — | — | — | 199,000Source | 402,000Source | 746,000Source | 979,000Source |
| General and Administrative ExpenseCAD | — | — | 3,124,000Source | 2,864,000Source | 4,178,000Source | 2,854,000Source | 3,308,000Source | 3,354,000Source | 14,735,000Source | 15,592,000Source | 19,812,000Source | 1,165,000Source |
| GrossProfitCAD | — | — | 2,464,000Source | 1,761,000Source | 3,197,000Source | 1,369,000Source | 2,954,000Source | 1,010,000Source | 13,548,000Source | 12,053,000Source | 11,563,000Source | 10,983,000Source |
| ImpairmentLossRecognisedInProfitOrLossGoodwillCAD | — | — | — | — | — | — | — | — | 0Source | 11,161,000Source | — | — |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillCAD | — | — | — | — | — | — | — | — | — | 3,870,000Source | — | — |
| IncomeTaxExpenseContinuingOperationsCAD | — | — | -18,000Source | -3,013,000Source | -778,000Source | -731,000Source | -182,000Source | -666,000Source | -4,033,000Source | -1,526,000Source | -1,192,000Source | 861,000Source |
| OtherOperatingIncomeExpenseCAD | — | — | -274,000Source | -106,000Source | -117,000Source | -224,000Source | 230,000Source | -4,000Source | -707,000Source | 421,000Source | 799,000Source | 900,000Source |
| ProfessionalFeesExpenseCAD | — | — | — | — | — | — | — | — | — | — | — | 2,615,000Source |
| ProfitLossBeforeTaxCAD | — | — | -3,948,000Source | -24,965,000Source | -3,457,000Source | -4,278,000Source | -2,591,000Source | -4,878,000Source | -34,267,000Source | -28,703,000Source | -27,752,000Source | -15,848,000Source |
| ResearchAndDevelopmentExpenseCAD | — | — | 1,214,000Source | 914,000Source | 1,001,000Source | 1,006,000Source | 835,000Source | 1,489,000Source | 4,943,000Source | 4,043,000Source | 12,280,000Source | 6,693,000Source |
Offerings
Registration 333-297424
Filing attachments
hyft-ex99_1.htm · 6-K/A · 2026-10-30
Exhibit 99.1 MINDWALK HOLDINGS CORP. Industrious 823 Congress Ave Suite 300 Austin, Texas 78701 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON NOVEMBER 17, 2026 AND INFORMATION CIRCULAR October 16, 2026 MINDWALK HOLDINGS CORP. Industrious 823 Congress Ave Suite 300 Austin, Texas 78701 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual general meeting (the “Meeting”) of the shareholders of MindWalk Holdings Corp. (the “Company”) wil…
Read attachment ↗hyft-ex99_2.htm · 6-K/A · 2026-10-30
MindWalk Holdings Corp. (the “Company”) MANAGEMENT INFORMATION CIRCULAR October 16, 2026 INTRODUCTION This management information circular (this “Information Circular”) accompanies the Notice of Annual General Meeting of Shareholders (the “Notice”) and is furnished to shareholders holding common shares (the “Common Shares”) in the capital of MindWalk Holdings Corp. (the “Company”) in connection with the solicitation by the management of the Company of proxies to be voted at the annual gener…
Read attachment ↗hyft-ex99_1.htm · 6-K · 2026-10-28
Exhibit 99.1 MINDWALK HOLDINGS CORP. Industrious 823 Congress Ave Suite 300 Austin, Texas 78701 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON NOVEMBER 17, 2026 AND INFORMATION CIRCULAR October 16, 2026 MINDWALK HOLDINGS CORP. Industrious 823 Congress Ave Suite 300 Austin, Texas 78701 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual general meeting (the “Meeting”) of the shareholders of MindWalk Holdings Corp. (the “Company”) wil…
Read attachment ↗hyft-ex99_2.htm · 6-K · 2026-10-28
MindWalk Holdings Corp. (the “Company”) MANAGEMENT INFORMATION CIRCULAR October 16, 2026 INTRODUCTION This management information circular (this “Information Circular”) accompanies the Notice of Annual General Meeting of Shareholders (the “Notice”) and is furnished to shareholders holding common shares (the “Common Shares”) in the capital of MindWalk Holdings Corp. (the “Company”) in connection with the solicitation by the management of the Company of proxies to be voted at the annual gener…
Read attachment ↗hyft-ex99_1.htm · 6-K · 2026-10-22
99.1 FOR IMMEDIATE RELEASE MindWalk Holdings Corp. Announces Leadership Update Commercial Priorities Unchanged; LensAI™ Remains in Contracted, Recurring Deployments with Life Sciences Customers AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that Thomas Lynch, PhD, has departed the company and ceased to serve as Chief Business Officer, effective October 16, 2026. "We thank Thomas for his contributions to MindWalk …
Read attachment ↗hyft-ex99_1.htm · 6-K · 2026-10-21
99.1 MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours New white paper shows LensAI™ immunogenicity screening running at up to 43% lower cost per sequence on Amazon EC2 Hpc8a instances powered by AMD EPYC processors, making a critical drug-safety check practical at the scale AI-driven discovery now demands AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its Le…
Read attachment ↗